Hyperhomocysteinemia in patients with symptomatic chronic heart failure: Prevalence and prognostic importance-pilot study

Atherosclerosis

Volumn 194, Issue 2, 2007, Pages 408-414

  Naruszewicz, Marek ^a   Jankowska, Ewa A ^b   Zymlinski, Robert ^b   Bukowska, Hanna ^a   Millo, Barbara ^a   Banasiak, Waldemar ^b   Ponikowski, Piotr ^b  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

^b MILITARY HOSPITAL   (Poland)

Author keywords

Chronic heart failure; Homocysteine; Prognosis

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; HOMOCYSTEINE;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HEART FAILURE; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERURICEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; MORTALITY; MULTIVARIATE ANALYSIS; OXYGEN CONSUMPTION; PILOT STUDY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL MODEL; SURVIVAL; URIC ACID BLOOD LEVEL;

AGED; FEMALE; HEART FAILURE; HUMANS; HYPERHOMOCYSTEINEMIA; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PILOT PROJECTS; POLAND; PREVALENCE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS;

EID: 34848843014     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.08.014     Document Type: Article

References (39)

1. The Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke. J Am Med Assoc 288 (2002) 2015-2022
2. Wald D.S., Law M., and Morris J.K. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 325 (2002) 1202-1206
3. De Bree A., Verschuren W.M.M., Kromhout D., Kluijtmans L.A.J., and Blom H.J. Homocysteine determinants and the evidence to what extent homocysteine determines the risk of coronary heart disease. Pharmacol Rev 54 (2002) 599-618
4. Austin R.C., Lentz S.R., and Werstuck G.H. Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease. Cell Death Differ 11 (2004) S56-S64
5. Stamler J.S., Osborn J.A., Jaraji O., et al. Adverse effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest 91 (1993) 308-318
6. Woo K.S., Chook P., Lolin Y.I., et al. Hyperhomocysteinemia is a risk factor for arterial endothelial dysfunction in humans. Circulation 96 (1997) 2542-2544
7. Naruszewicz M., Klinke M., Dziewanowski K., Staniewicz A., and Bukowska H. Homocysteine, fibrinogen, and lipoprotein(a) levels are simultaneously reduced in patients with chronic renal failure treated with folic acid, pyridoxine, and cyanocobalamin. Metabolism 50 (2001) 131-134
8. Welch G.N., and Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 338 (1998) 1042-1050
9. Joseph J., Joseph L., Nawal S., et al. Hyperhomocysteinemia leads to pathological ventricular hypertrophy in normotensive rats. Am J Physiol Heart Circ Physiol 285 (2003) H679-H686
10. Blacher J., Demuth K., Guerin A.P., et al. Association between plasma homocysteine concentrations and cardiac hypertrophy in end-stage renal disease. J Nephrol 12 (1999) 248-255
11. Kennedy R.H., Owings R., Shekhawat N., and Joseph J. Acute negative inotropic effects of homocysteine are mediated via the endothelium. Am J Physiol Heart Circ Physiol 287 (2004) H812-H817
12. Joseph J., Washington A., Joseph L., et al. Hyperhomocysteinemia leads to adverse cardiac remodeling in hypertensive rats. Am J Physiol Heart Circ Physiol 283 (2002) H2567-H2574
13. Herrmann M, Taban-Shomal O, Hubner U, Bohm M, Herrmann W. A review of homocysteine and heart failure. Eur J Heart Fail, in press.
14. Vasan R.S., Beiser A., D'Agostino R.B., et al. Plasma homocysteine and risk for congestive heart failure in adults without prior myocardial infarction. J Am Med Assoc 289 (2003) 1251-1257
15. Cooke G.E., Eaton G.M., Whitby G., et al. Plasma atherogenic markers in congestive heart failure and posttransplant (heart) patients. J Am Coll Cardiol 36 (2000) 509-516
16. Cook R.C., Parker S., Kingsbury K., et al. Effective treatment of hyperhomocysteinemia in heart transplant recipients with and without renal failure. J Heart Lung Transplant 20 (2001) 310-315
17. Ventura P., Panini R., Verlato C., Scarpetta G., and Salvioli G. Hyperhomocysteinemia and Related Factors in 600 Hospitalized Elderly Subjects. Metabolism 50 (2001) 1466-1471
18. Herrmann M., Kindermann I., Muller S., Georg T., Kindermann M., Bohm M., and Herrmann W. Relationship of plasma homocysteine with the severity of chronic heart failure. Clin Chem 51 (2005) 1512-1515
19. Barbé F., Abdelmouttaleb I., Chango A., et al. Detection of moderate hyperhomocysteinemia: comparison of the Abbott fluorescence polarization immunoassay with the Bio-Rad and SBD-F high-performance liquid chromatographic assays. Amino Acids 20 (2001) 435-440
20. Van der Berg M., Stehouwer C.D.A., Biedrager E., et al. Plasma homocysteine and severity of atherosclerosis in young patients with lower limb atherosclerotic disease. Atheroscler Thromb Vasc Biol 16 (1996) 165-171
21. Gupta R., Birnbaum Y., and Urestsky B.F. The renal patient with coronary artery disease. J Am Coll Cardiol 44 (2004) 1343-1353
22. Ponikowski P., Francis D.P., Piepoli M.F., et al. Enhanced ventilatory response to exercise in patients with chronic heart failure and preserved exercise tolerance: marker of abnormal cardiorespiratory reflex control and predictor of poor prognosis. Circulation 103 (2001) 967-972
23. Chen P., Poddar R., Tipa E.V., et al. Homocysteine metabolism in cardiovascular cells and tissues: implications for hyperhomocysteinemia and cardiovascular disease. Adv Enzyme Regul 39 (1999) 93-109
24. Bostom A.G., and Selhub J. Homocysteine and arteriosclerosis. Circulation 99 (1999) 363-375
25. Selhub J., Jacques P.F., Wilson P.W.F., Rush D., and Rosenberg I.H. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. J Am Med Assoc 270 (1993) 2693-2698
26. Witte K.K.A., Clark A.L., and Cleland J.G.F. Chronic heart failure and micronutrients. J Am Coll Cardiol 37 (2001) 1765-1774
27. Herrmann W., Quast S., Ullrich M., et al. Hyperhomocysteinemia in high-aged subjects: Relation of B-vitamins, folic acid, renal function and the methylene tetrahydrofolate reductase mutation. Atherosclerosis 144 (1999) 91-101
28. Jankowska EA, Ponikowska B, Majda J, et al. Hyperuricaemia predicts poor outcome in patients with mild to moderate chronic heart failure. Int J Cardiol, in press.
29. Leyva F., Anker S.D., Godsland I., et al. Uric acid in chronic heart failure: a marker of chronic inflammation. Eur Heart J 19 (1998) 1814-1822
30. Anker S.D., Leyva F., Poole-Wilson P.A., et al. Relation between serum uric acid and lower limb blood flow in patients with chronic heart failure. Heart 78 (1997) 39-43
31. O'Dochartaigh C., Ong H., Lovell S., et al. Changes in pulmonary vascular function after acute methionine loading in normal men. Clin Sci 106 (2004) 413-419
32. Schnyder G., Roffi M., Pin R., et al. Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. N Engl J Med 345 (2001) 1593-1600
33. Homocysteine Lowering Trialists' Collaboration,. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomized trials. BMJ 316 (1998) 894-898
34. Woo K.S., Chook P., Lolin Y.I., et al. Folic acid improves arterial endothelial function in adults with hyperhomocystinemia. J Am Coll Cardiol 34 (1999) 2002-2006
35. Chambers J.C., Ueland P.M., Obeid O.A., et al. Improved vascular endothelial function after oral B vitamins: an effect mediated through reduced concentrations of free plasma homocysteine. Circulation 102 (2000) 2479-2483
36. Nygard O., Nordrehaug J.E., Refsum H., et al. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 337 (1997) 230-236
37. Bostom A.G., Silbershatz H., Rosenberg I.C.H., et al. Nonfasting plasma total homocysteine levels and all-cause and cardio-vascular disease mortality in elderly Framingham men and women. Arch Intern Med 159 (1999) 1077-1080
38. Anker S.D., Doehner W., Rauchhaus M., et al. Uric acid and survival in chronic heart failure: validation and application in metabolic, functional and hemodynamic staging. Circulation 107 (2003) 1991-1997
39. Raeder S., Landaas S., Laake K., Lyberg T., and Engedal K. Homocysteine measurements in geriatric patients. Scand J Clin Lab Invest 66 (2006) 309-316